INMB
Inmune Bio
$1.73
+$0.11 (+6.79%)Jul 27, 2026
Key metrics
The numbers that frame INMB today
- Market cap
- $45.99M
- P/E (TTM)
- -1.1
- EV / FCF
- -1.3
- ROIC
- 4,524.3%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.09
- 52wk High
- $3.24
Growth
Revenue and earnings trend for INMB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INMB
Is Inmune Bio a good buy?
No. Inmune Bio has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Inmune Bio is selling at a very high price.
What is the market capitalization of INMB?
Inmune Bio's market capitalization is $45.99M.
What is the P/E ratio for INMB stock?
Inmune Bio's current P/E ratio is -1.1.
What is the 52-week high for INMB stock?
The 52-week high for Inmune Bio is $3.24. The current close of $1.73 is 46.7% below that high.
What is the 52-week low for INMB stock?
The 52-week low for Inmune Bio is $1.09. The current close of $1.73 is 58.7% above that low.
Does INMB stock pay dividends?
Inmune Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INMB?
Inmune Bio's Debt / Equity ratio is 0.08.